1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Renal Diseases Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Chronic Kidney Disease (CKD) Drugs 1.2.3 End-Stage Kidney Disease (ESRD) Drugs 1.3 Market by Application 1.3.1 Global Renal Diseases Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Specialty Clinics 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Renal Diseases Drug Market Perspective (2016-2027) 2.2 Renal Diseases Drug Growth Trends by Regions 2.2.1 Renal Diseases Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Renal Diseases Drug Historic Market Share by Regions (2016-2021) 2.2.3 Renal Diseases Drug Forecasted Market Size by Regions (2022-2027) 2.3 Renal Diseases Drug Industry Dynamic 2.3.1 Renal Diseases Drug Market Trends 2.3.2 Renal Diseases Drug Market Drivers 2.3.3 Renal Diseases Drug Market Challenges 2.3.4 Renal Diseases Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Renal Diseases Drug Players by Revenue 3.1.1 Global Top Renal Diseases Drug Players by Revenue (2016-2021) 3.1.2 Global Renal Diseases Drug Revenue Market Share by Players (2016-2021) 3.2 Global Renal Diseases Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Renal Diseases Drug Revenue 3.4 Global Renal Diseases Drug Market Concentration Ratio 3.4.1 Global Renal Diseases Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Renal Diseases Drug Revenue in 2020 3.5 Renal Diseases Drug Key Players Head office and Area Served 3.6 Key Players Renal Diseases Drug Product Solution and Service 3.7 Date of Enter into Renal Diseases Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Renal Diseases Drug Breakdown Data by Type 4.1 Global Renal Diseases Drug Historic Market Size by Type (2016-2021) 4.2 Global Renal Diseases Drug Forecasted Market Size by Type (2022-2027) 5 Renal Diseases Drug Breakdown Data by Application 5.1 Global Renal Diseases Drug Historic Market Size by Application (2016-2021) 5.2 Global Renal Diseases Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Renal Diseases Drug Market Size (2016-2027) 6.2 North America Renal Diseases Drug Market Size by Type 6.2.1 North America Renal Diseases Drug Market Size by Type (2016-2021) 6.2.2 North America Renal Diseases Drug Market Size by Type (2022-2027) 6.2.3 North America Renal Diseases Drug Market Size by Type (2016-2027) 6.3 North America Renal Diseases Drug Market Size by Application 6.3.1 North America Renal Diseases Drug Market Size by Application (2016-2021) 6.3.2 North America Renal Diseases Drug Market Size by Application (2022-2027) 6.3.3 North America Renal Diseases Drug Market Size by Application (2016-2027) 6.4 North America Renal Diseases Drug Market Size by Country 6.4.1 North America Renal Diseases Drug Market Size by Country (2016-2021) 6.4.2 North America Renal Diseases Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Renal Diseases Drug Market Size (2016-2027) 7.2 Europe Renal Diseases Drug Market Size by Type 7.2.1 Europe Renal Diseases Drug Market Size by Type (2016-2021) 7.2.2 Europe Renal Diseases Drug Market Size by Type (2022-2027) 7.2.3 Europe Renal Diseases Drug Market Size by Type (2016-2027) 7.3 Europe Renal Diseases Drug Market Size by Application 7.3.1 Europe Renal Diseases Drug Market Size by Application (2016-2021) 7.3.2 Europe Renal Diseases Drug Market Size by Application (2022-2027) 7.3.3 Europe Renal Diseases Drug Market Size by Application (2016-2027) 7.4 Europe Renal Diseases Drug Market Size by Country 7.4.1 Europe Renal Diseases Drug Market Size by Country (2016-2021) 7.4.2 Europe Renal Diseases Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Renal Diseases Drug Market Size (2016-2027) 8.2 Asia-Pacific Renal Diseases Drug Market Size by Type 8.2.1 Asia-Pacific Renal Diseases Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Renal Diseases Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Renal Diseases Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Renal Diseases Drug Market Size by Application 8.3.1 Asia-Pacific Renal Diseases Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Renal Diseases Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Renal Diseases Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Renal Diseases Drug Market Size by Region 8.4.1 Asia-Pacific Renal Diseases Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Renal Diseases Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Renal Diseases Drug Market Size (2016-2027) 9.2 Latin America Renal Diseases Drug Market Size by Type 9.2.1 Latin America Renal Diseases Drug Market Size by Type (2016-2021) 9.2.2 Latin America Renal Diseases Drug Market Size by Type (2022-2027) 9.2.3 Latin America Renal Diseases Drug Market Size by Type (2016-2027) 9.3 Latin America Renal Diseases Drug Market Size by Application 9.3.1 Latin America Renal Diseases Drug Market Size by Application (2016-2021) 9.3.2 Latin America Renal Diseases Drug Market Size by Application (2022-2027) 9.3.3 Latin America Renal Diseases Drug Market Size by Application (2016-2027) 9.4 Latin America Renal Diseases Drug Market Size by Country 9.4.1 Latin America Renal Diseases Drug Market Size by Country (2016-2021) 9.4.2 Latin America Renal Diseases Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Renal Diseases Drug Market Size (2016-2027) 10.2 Middle East & Africa Renal Diseases Drug Market Size by Type 10.2.1 Middle East & Africa Renal Diseases Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Renal Diseases Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Renal Diseases Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Renal Diseases Drug Market Size by Application 10.3.1 Middle East & Africa Renal Diseases Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Renal Diseases Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Renal Diseases Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Renal Diseases Drug Market Size by Country 10.4.1 Middle East & Africa Renal Diseases Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Renal Diseases Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Renal Diseases Drug Introduction 11.1.4 Pfizer Revenue in Renal Diseases Drug Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Amgen 11.2.1 Amgen Company Details 11.2.2 Amgen Business Overview 11.2.3 Amgen Renal Diseases Drug Introduction 11.2.4 Amgen Revenue in Renal Diseases Drug Business (2016-2021) 11.2.5 Amgen Recent Development 11.3 Roche 11.3.1 Roche Company Details 11.3.2 Roche Business Overview 11.3.3 Roche Renal Diseases Drug Introduction 11.3.4 Roche Revenue in Renal Diseases Drug Business (2016-2021) 11.3.5 Roche Recent Development 11.4 GlaxoSmithKline (GSK) 11.4.1 GlaxoSmithKline (GSK) Company Details 11.4.2 GlaxoSmithKline (GSK) Business Overview 11.4.3 GlaxoSmithKline (GSK) Renal Diseases Drug Introduction 11.4.4 GlaxoSmithKline (GSK) Revenue in Renal Diseases Drug Business (2016-2021) 11.4.5 GlaxoSmithKline (GSK) Recent Development 11.5 Allergan 11.5.1 Allergan Company Details 11.5.2 Allergan Business Overview 11.5.3 Allergan Renal Diseases Drug Introduction 11.5.4 Allergan Revenue in Renal Diseases Drug Business (2016-2021) 11.5.5 Allergan Recent Development 11.6 AbbVie 11.6.1 AbbVie Company Details 11.6.2 AbbVie Business Overview 11.6.3 AbbVie Renal Diseases Drug Introduction 11.6.4 AbbVie Revenue in Renal Diseases Drug Business (2016-2021) 11.6.5 AbbVie Recent Development 11.7 Kissei Pharmaceutical 11.7.1 Kissei Pharmaceutical Company Details 11.7.2 Kissei Pharmaceutical Business Overview 11.7.3 Kissei Pharmaceutical Renal Diseases Drug Introduction 11.7.4 Kissei Pharmaceutical Revenue in Renal Diseases Drug Business (2016-2021) 11.7.5 Kissei Pharmaceutical Recent Development 11.8 AstraZeneca 11.8.1 AstraZeneca Company Details 11.8.2 AstraZeneca Business Overview 11.8.3 AstraZeneca Renal Diseases Drug Introduction 11.8.4 AstraZeneca Revenue in Renal Diseases Drug Business (2016-2021) 11.8.5 AstraZeneca Recent Development 11.9 FibroGen 11.9.1 FibroGen Company Details 11.9.2 FibroGen Business Overview 11.9.3 FibroGen Renal Diseases Drug Introduction 11.9.4 FibroGen Revenue in Renal Diseases Drug Business (2016-2021) 11.9.5 FibroGen Recent Development 11.10 Sanofi 11.10.1 Sanofi Company Details 11.10.2 Sanofi Business Overview 11.10.3 Sanofi Renal Diseases Drug Introduction 11.10.4 Sanofi Revenue in Renal Diseases Drug Business (2016-2021) 11.10.5 Sanofi Recent Development 11.11 Teva Pharmaceutical Industries 11.11.1 Teva Pharmaceutical Industries Company Details 11.11.2 Teva Pharmaceutical Industries Business Overview 11.11.3 Teva Pharmaceutical Industries Renal Diseases Drug Introduction 11.11.4 Teva Pharmaceutical Industries Revenue in Renal Diseases Drug Business (2016-2021) 11.11.5 Teva Pharmaceutical Industries Recent Development 11.12 Johnson & Johnson 11.12.1 Johnson & Johnson Company Details 11.12.2 Johnson & Johnson Business Overview 11.12.3 Johnson & Johnson Renal Diseases Drug Introduction 11.12.4 Johnson & Johnson Revenue in Renal Diseases Drug Business (2016-2021) 11.12.5 Johnson & Johnson Recent Development 11.13 Keryx Biopharmaceuticals 11.13.1 Keryx Biopharmaceuticals Company Details 11.13.2 Keryx Biopharmaceuticals Business Overview 11.13.3 Keryx Biopharmaceuticals Renal Diseases Drug Introduction 11.13.4 Keryx Biopharmaceuticals Revenue in Renal Diseases Drug Business (2016-2021) 11.13.5 Keryx Biopharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Renal Diseases Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Chronic Kidney Disease (CKD) Drugs Table 3. Key Players of End-Stage Kidney Disease (ESRD) Drugs Table 4. Global Renal Diseases Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Renal Diseases Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Renal Diseases Drug Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Renal Diseases Drug Market Share by Regions (2016-2021) Table 8. Global Renal Diseases Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Renal Diseases Drug Market Share by Regions (2022-2027) Table 10. Renal Diseases Drug Market Trends Table 11. Renal Diseases Drug Market Drivers Table 12. Renal Diseases Drug Market Challenges Table 13. Renal Diseases Drug Market Restraints Table 14. Global Renal Diseases Drug Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Renal Diseases Drug Market Share by Players (2016-2021) Table 16. Global Top Renal Diseases Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Diseases Drug as of 2020) Table 17. Ranking of Global Top Renal Diseases Drug Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Renal Diseases Drug Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Renal Diseases Drug Product Solution and Service Table 21. Date of Enter into Renal Diseases Drug Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Renal Diseases Drug Market Size by Type (2016-2021) (US$ Million) Table 24. Global Renal Diseases Drug Revenue Market Share by Type (2016-2021) Table 25. Global Renal Diseases Drug Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Renal Diseases Drug Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Renal Diseases Drug Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Renal Diseases Drug Revenue Market Share by Application (2016-2021) Table 29. Global Renal Diseases Drug Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Renal Diseases Drug Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Renal Diseases Drug Market Size by Type (2016-2021) (US$ Million) Table 32. North America Renal Diseases Drug Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Renal Diseases Drug Market Size by Application (2016-2021) (US$ Million) Table 34. North America Renal Diseases Drug Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Renal Diseases Drug Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Renal Diseases Drug Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Renal Diseases Drug Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Renal Diseases Drug Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Renal Diseases Drug Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Renal Diseases Drug Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Renal Diseases Drug Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Renal Diseases Drug Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Renal Diseases Drug Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Renal Diseases Drug Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Renal Diseases Drug Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Renal Diseases Drug Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Renal Diseases Drug Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Renal Diseases Drug Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Renal Diseases Drug Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Renal Diseases Drug Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Renal Diseases Drug Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Renal Diseases Drug Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Renal Diseases Drug Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Renal Diseases Drug Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Renal Diseases Drug Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Renal Diseases Drug Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Renal Diseases Drug Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Renal Diseases Drug Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Renal Diseases Drug Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Renal Diseases Drug Market Size by Country (2022-2027) & (US$ Million) Table 61. Pfizer Company Details Table 62. Pfizer Business Overview Table 63. Pfizer Renal Diseases Drug Product Table 64. Pfizer Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million) Table 65. Pfizer Recent Development Table 66. Amgen Company Details Table 67. Amgen Business Overview Table 68. Amgen Renal Diseases Drug Product Table 69. Amgen Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million) Table 70. Amgen Recent Development Table 71. Roche Company Details Table 72. Roche Business Overview Table 73. Roche Renal Diseases Drug Product Table 74. Roche Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million) Table 75. Roche Recent Development Table 76. GlaxoSmithKline (GSK) Company Details Table 77. GlaxoSmithKline (GSK) Business Overview Table 78. GlaxoSmithKline (GSK) Renal Diseases Drug Product Table 79. GlaxoSmithKline (GSK) Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million) Table 80. GlaxoSmithKline (GSK) Recent Development Table 81. Allergan Company Details Table 82. Allergan Business Overview Table 83. Allergan Renal Diseases Drug Product Table 84. Allergan Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million) Table 85. Allergan Recent Development Table 86. AbbVie Company Details Table 87. AbbVie Business Overview Table 88. AbbVie Renal Diseases Drug Product Table 89. AbbVie Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million) Table 90. AbbVie Recent Development Table 91. Kissei Pharmaceutical Company Details Table 92. Kissei Pharmaceutical Business Overview Table 93. Kissei Pharmaceutical Renal Diseases Drug Product Table 94. Kissei Pharmaceutical Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million) Table 95. Kissei Pharmaceutical Recent Development Table 96. AstraZeneca Company Details Table 97. AstraZeneca Business Overview Table 98. AstraZeneca Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million) Table 99. AstraZeneca Recent Development Table 100. FibroGen Company Details Table 101. FibroGen Business Overview Table 102. FibroGen Renal Diseases Drug Product Table 103. FibroGen Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million) Table 104. FibroGen Recent Development Table 105. Sanofi Company Details Table 106. Sanofi Business Overview Table 107. Sanofi Renal Diseases Drug Product Table 108. Sanofi Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million) Table 109. Sanofi Recent Development Table 110. Teva Pharmaceutical Industries Company Details Table 111. Teva Pharmaceutical Industries Business Overview Table 112. Teva Pharmaceutical Industries Renal Diseases Drug Product Table 113. Teva Pharmaceutical Industries Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million) Table 114. Teva Pharmaceutical Industries Recent Development Table 115. Johnson & Johnson Company Details Table 116. Johnson & Johnson Business Overview Table 117. Johnson & Johnson Renal Diseases Drug Product Table 118. Johnson & Johnson Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million) Table 119. Johnson & Johnson Recent Development Table 120. Keryx Biopharmaceuticals Company Details Table 121. Keryx Biopharmaceuticals Business Overview Table 122. Keryx Biopharmaceuticals Renal Diseases Drug Product Table 123. Keryx Biopharmaceuticals Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million) Table 124. Keryx Biopharmaceuticals Recent Development Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Global Renal Diseases Drug Market Share by Type: 2020 VS 2027 Figure 2. Chronic Kidney Disease (CKD) Drugs Features Figure 3. End-Stage Kidney Disease (ESRD) Drugs Features Figure 4. Global Renal Diseases Drug Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. Specialty Clinics Case Studies Figure 7. Other Case Studies Figure 8. Renal Diseases Drug Report Years Considered Figure 9. Global Renal Diseases Drug Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Renal Diseases Drug Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Renal Diseases Drug Market Share by Regions: 2020 VS 2027 Figure 12. Global Renal Diseases Drug Market Share by Regions (2022-2027) Figure 13. Global Renal Diseases Drug Market Share by Players in 2020 Figure 14. Global Top Renal Diseases Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Diseases Drug as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Renal Diseases Drug Revenue in 2020 Figure 16. Global Renal Diseases Drug Revenue Market Share by Type (2016-2021) Figure 17. Global Renal Diseases Drug Revenue Market Share by Type (2022-2027) Figure 18. North America Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Renal Diseases Drug Market Share by Type (2016-2027) Figure 20. North America Renal Diseases Drug Market Share by Application (2016-2027) Figure 21. North America Renal Diseases Drug Market Share by Country (2016-2027) Figure 22. United States Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Renal Diseases Drug Market Share by Type (2016-2027) Figure 26. Europe Renal Diseases Drug Market Share by Application (2016-2027) Figure 27. Europe Renal Diseases Drug Market Share by Country (2016-2027) Figure 28. Germany Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Renal Diseases Drug Market Share by Type (2016-2027) Figure 36. Asia-Pacific Renal Diseases Drug Market Share by Application (2016-2027) Figure 37. Asia-Pacific Renal Diseases Drug Market Share by Region (2016-2027) Figure 38. China Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Renal Diseases Drug Market Share by Type (2016-2027) Figure 46. Latin America Renal Diseases Drug Market Share by Application (2016-2027) Figure 47. Latin America Renal Diseases Drug Market Share by Country (2016-2027) Figure 48. Mexico Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Renal Diseases Drug Market Share by Type (2016-2027) Figure 52. Middle East & Africa Renal Diseases Drug Market Share by Application (2016-2027) Figure 53. Middle East & Africa Renal Diseases Drug Market Share by Country (2016-2027) Figure 54. Turkey Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Pfizer Revenue Growth Rate in Renal Diseases Drug Business (2016-2021) Figure 58. Amgen Revenue Growth Rate in Renal Diseases Drug Business (2016-2021) Figure 59. Roche Revenue Growth Rate in Renal Diseases Drug Business (2016-2021) Figure 60. GlaxoSmithKline (GSK) Revenue Growth Rate in Renal Diseases Drug Business (2016-2021) Figure 61. Allergan Revenue Growth Rate in Renal Diseases Drug Business (2016-2021) Figure 62. AbbVie Revenue Growth Rate in Renal Diseases Drug Business (2016-2021) Figure 63. Kissei Pharmaceutical Revenue Growth Rate in Renal Diseases Drug Business (2016-2021) Figure 64. AstraZeneca Revenue Growth Rate in Renal Diseases Drug Business (2016-2021) Figure 65. FibroGen Revenue Growth Rate in Renal Diseases Drug Business (2016-2021) Figure 66. Sanofi Revenue Growth Rate in Renal Diseases Drug Business (2016-2021) Figure 67. Teva Pharmaceutical Industries Revenue Growth Rate in Renal Diseases Drug Business (2016-2021) Figure 68. Johnson & Johnson Revenue Growth Rate in Renal Diseases Drug Business (2016-2021) Figure 69. Keryx Biopharmaceuticals Revenue Growth Rate in Renal Diseases Drug Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Pfizer Amgen Roche GlaxoSmithKline (GSK) Allergan AbbVie Kissei Pharmaceutical AstraZeneca FibroGen Sanofi Teva Pharmaceutical Industries Johnson & Johnson Keryx Biopharmaceuticals